Trials / Recruiting
RecruitingNCT06375447
Intelligent Diagnosis and Treatment Model for Insomnia Disorder
Study on an Intelligent Model for the Diagnosis and Treatment of Insomnia Disorder
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 16,000 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.
Detailed description
The study endeavors to establish a multicenter cohort comprising 16,000 individuals diagnosed with insomnia disorder, with a subsequent 2-year follow-up. Objectives encompass elucidating the natural development of insomnia disorder within diverse populations, identifying associated factors, and evaluating the short-term and long-term impacts on physiological, psychological, and social functions in insomnia disorder. Additionally, the research aims to devise early screening methodologies, precise assessments, and innovative disease classifications utilizing real-time assessment technology within the insomnia disorder cohort. Furthermore, the investigation seeks to ascertain graded diagnoses, treatment modalities, and prognostic indicators based on advanced multi-dimensional real-time assessment technology applied to a substantial insomnia disorder cohort. Finally, the study aims to refine remote interactive diagnostic and treatment modalities tailored to diverse age groups, culminating in developing a systematic graded diagnostic and treatment framework for insomnia disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Routine clinical treatment | Routine clinical treatment is based on the latest international guidelines for insomnia. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
- First posted
- 2024-04-19
- Last updated
- 2024-12-10
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06375447. Inclusion in this directory is not an endorsement.